Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes

Documenti analoghi

• Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial
  di: Kamel Mohammedi, et al.
  Pubblicazione: (2024)
• Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial
  di: Abderrahim Oulhaj, et al.
  Pubblicazione: (2024)
• A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes
  di: Olivier Bourron, et al.
  Pubblicazione: (2024)
• Triglyceride variability and risk of heart failure events in type 2 diabetes: Results from the ACCORD trial
  di: Daniel S. Nuyujukian, et al.
  Pubblicazione: (2025)
• Development and first‐stage validation of a digital version of the Digit Symbol Substitution test for use in assessing cognitive function in older people with diabetes
  di: Omri Segev, et al.
  Pubblicazione: (2024)